AAAAAA

   
Results: 1-25 | 26-50 | 51-57
Results: 1-25/57
CELL-CYCLE REGULATION OF HUMAN PANCREATIC-CANCER BY TAMOXIFEN
Authors: ROBINSON EK GRAU AM EVANS DB SMID CM CHIAO PJ ABBRUZZESE JL GRIMM EA
Citation: Ek. Robinson et al., CELL-CYCLE REGULATION OF HUMAN PANCREATIC-CANCER BY TAMOXIFEN, Annals of surgical oncology, 5(4), 1998, pp. 342-349
CLINICAL-RESULTS OF A PHARMACODYNAMICALLY-BASED STRATEGY FOR HIGHER DOSING OF GEMCITABINE IN PATIENTS WITH SOLID TUMORS
Authors: TOUROUTOGLOU N GRAVEL D RABER MN PLUNKETT W ABBRUZZESE JL
Citation: N. Touroutoglou et al., CLINICAL-RESULTS OF A PHARMACODYNAMICALLY-BASED STRATEGY FOR HIGHER DOSING OF GEMCITABINE IN PATIENTS WITH SOLID TUMORS, Annals of oncology, 9(9), 1998, pp. 1003-1008
DETECTION OF PRIMARY BREAST-CANCER PRESENTING AS METASTATIC CARCINOMAOF UNKNOWN PRIMARY ORIGIN BY IN-111-PENTETREOTIDE SCAN
Authors: LENZI R KIM EE RABER MN ABBRUZZESE JL
Citation: R. Lenzi et al., DETECTION OF PRIMARY BREAST-CANCER PRESENTING AS METASTATIC CARCINOMAOF UNKNOWN PRIMARY ORIGIN BY IN-111-PENTETREOTIDE SCAN, Annals of oncology, 9(2), 1998, pp. 213-216
UNKNOWN PRIMARY TUMORS METASTATIC TO LIVER
Authors: AYOUB JP HESS KR ABBRUZZESE MC LENZI R RABER MN ABBRUZZESE JL
Citation: Jp. Ayoub et al., UNKNOWN PRIMARY TUMORS METASTATIC TO LIVER, Journal of clinical oncology, 16(6), 1998, pp. 2105-2112
QUANTITATION OF DOLASTATIN-10 USING HPLC ELECTROSPRAY IONIZATION MASS-SPECTROMETRY - APPLICATION IN A PHASE-I CLINICAL-TRIAL/
Authors: GARTEIZ DA MADDEN T BECK DE HUIE WR MCMANUS KT ABBRUZZESE JL CHEN W NEWMAN RA
Citation: Da. Garteiz et al., QUANTITATION OF DOLASTATIN-10 USING HPLC ELECTROSPRAY IONIZATION MASS-SPECTROMETRY - APPLICATION IN A PHASE-I CLINICAL-TRIAL/, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 299-306
PREOPERATIVE CHEMORADIATION AND PANCREATICODUODENECTOMY FOR ADENOCARCINOMA OF THE PANCREAS
Authors: MILLER AR PISTERS PWT LEE JE JANJAN NA ABBRUZZESE JL EVANS DB
Citation: Ar. Miller et al., PREOPERATIVE CHEMORADIATION AND PANCREATICODUODENECTOMY FOR ADENOCARCINOMA OF THE PANCREAS, Hepato-gastroenterology, 45(21), 1998, pp. 624-633
MOLECULAR-GENETICS OF PANCREATIC-CANCER
Authors: BOLD RJ EVANS DB HESS KR GRAU AM SINICROPE F CLEARY KR CHIAO PJ ABBRUZZESE JL
Citation: Rj. Bold et al., MOLECULAR-GENETICS OF PANCREATIC-CANCER, Gastroenterology, 114(4), 1998, pp. 29-29
DNA-ADDUCTS IN HUMAN PANCREATIC TISSUES AND THEIR POTENTIAL ROLE IN CARCINOGENESIS
Authors: WANG MY ABBRUZZESE JL FRIESS H HITTELMAN WN EVANS DB ABBRUZZESE MC CHIAO P LI DH
Citation: My. Wang et al., DNA-ADDUCTS IN HUMAN PANCREATIC TISSUES AND THEIR POTENTIAL ROLE IN CARCINOGENESIS, Cancer research, 58(1), 1998, pp. 38-41
DIFFERENTIAL-EFFECTS ON FAST INACTIVATION OF DOMAIN-IV S4 CHARGE NEUTRALIZATIONS
Authors: ABBRUZZESE JL FUJIMOTO E RUBEN PC
Citation: Jl. Abbruzzese et al., DIFFERENTIAL-EFFECTS ON FAST INACTIVATION OF DOMAIN-IV S4 CHARGE NEUTRALIZATIONS, Biophysical journal, 74(2), 1998, pp. 401-401
DOCETAXEL ENHANCES TUMOR RADIORESPONSE IN-VIVO
Authors: MASON KA HUNTER NR MILAS M ABBRUZZESE JL MILAS L
Citation: Ka. Mason et al., DOCETAXEL ENHANCES TUMOR RADIORESPONSE IN-VIVO, Clinical cancer research, 3(12), 1997, pp. 2431-2438
ADENOVIRAL-MEDIATED WILD-TYPE P53 TUMOR-SUPPRESSOR GENE-THERAPY INDUCES APOPTOSIS AND SUPPRESSES GROWTH OF HUMAN PANCREATIC-CANCER
Authors: BOUVET M BOLD RJ FANG B EVANS DB ABBRUZZESE JL CHIAO PJ CHANDRA J MCCONKEY DJ ROTH JA
Citation: M. Bouvet et al., ADENOVIRAL-MEDIATED WILD-TYPE P53 TUMOR-SUPPRESSOR GENE-THERAPY INDUCES APOPTOSIS AND SUPPRESSES GROWTH OF HUMAN PANCREATIC-CANCER, Cancer gene therapy, 4(6), 1997, pp. 26-26
PHASE-II TRIAL OF 9-AMINOCAMPTOTHECIN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN METASTATIC COLORECTAL-CARCINOMA
Authors: PAZDUR R DIAZCANTON E BALLARD WP BRADOF JE GRAHAM S ARBUCK SG ABBRUZZESE JL WINN R
Citation: R. Pazdur et al., PHASE-II TRIAL OF 9-AMINOCAMPTOTHECIN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN METASTATIC COLORECTAL-CARCINOMA, Journal of clinical oncology, 15(8), 1997, pp. 2905-2909
POORLY DIFFERENTIATED CARCINOMA AND POORLY DIFFERENTIATED ADENOCARCINOMA OF UNKNOWN ORIGIN - FAVORABLE SUBSETS OF PATIENTS WITH UNKNOWN-PRIMARY CARCINOMA
Authors: LENZI R HESS KR ABBRUZZESE MC RABER MN ORDONEZ NG ABBRUZZESE JL
Citation: R. Lenzi et al., POORLY DIFFERENTIATED CARCINOMA AND POORLY DIFFERENTIATED ADENOCARCINOMA OF UNKNOWN ORIGIN - FAVORABLE SUBSETS OF PATIENTS WITH UNKNOWN-PRIMARY CARCINOMA, Journal of clinical oncology, 15(5), 1997, pp. 2056-2066
PREOPERATIVE AND POSTOPERATIVE CHEMORADIATION STRATEGIES IN PATIENTS TREATED WITH PANCREATICODUODENECTOMY FOR ADENOCARCINOMA OF THE PANCREAS
Authors: SPITZ FR ABBRUZZESE JL LEE JE PISTERS PWT LOWY AM FENOGLIO CJ CLEARY KR JANJAN NA GOSWITZ MS RICH TA EVANS DB
Citation: Fr. Spitz et al., PREOPERATIVE AND POSTOPERATIVE CHEMORADIATION STRATEGIES IN PATIENTS TREATED WITH PANCREATICODUODENECTOMY FOR ADENOCARCINOMA OF THE PANCREAS, Journal of clinical oncology, 15(3), 1997, pp. 928-937
HYPOFRACTIONATION, NOT RAPID-FRACTIONATION - REPLY
Authors: RICH TA JANJAN NA ABBRUZZESE JL EVANS DB
Citation: Ta. Rich et al., HYPOFRACTIONATION, NOT RAPID-FRACTIONATION - REPLY, Journal of clinical oncology, 15(10), 1997, pp. 3292-3293
PHASE-II TRIAL OF INTRAVENOUS CI-980 (NSC-370147) IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA - MODEL FOR PROSPECTIVE EVALUATION OF NEUROTOXICITY
Authors: PAZDUR R MEYERS C DIAZCANTON E ABBRUZZESE JL PATT Y GROVE W AJANI J
Citation: R. Pazdur et al., PHASE-II TRIAL OF INTRAVENOUS CI-980 (NSC-370147) IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA - MODEL FOR PROSPECTIVE EVALUATION OF NEUROTOXICITY, American journal of clinical oncology, 20(6), 1997, pp. 573-576
DETECTION OF MUTATED C-KI-RAS IN THE BILE OF PATIENTS WITH PANCREATIC-CANCER
Authors: ABBRUZZESE JL EVANS DB RAIJMAN I LARRY L KING T LEACH SD FRAZIER ML
Citation: Jl. Abbruzzese et al., DETECTION OF MUTATED C-KI-RAS IN THE BILE OF PATIENTS WITH PANCREATIC-CANCER, Anticancer research, 17(2A), 1997, pp. 795-801
GROWTH-INHIBITORY EFFECTS OF SODIUM PHENYLACETATE (NSC-3039) ON OVARIAN-CARCINOMA CELLS IN-VITRO
Authors: FERRANDINA G MELICHAR B LOERCHER A VERSCHRAEGEN CF KUDELKA AP EDWARDS CL SCAMBIA G KAVANAGH JJ ABBRUZZESE JL FREEDMAN RS
Citation: G. Ferrandina et al., GROWTH-INHIBITORY EFFECTS OF SODIUM PHENYLACETATE (NSC-3039) ON OVARIAN-CARCINOMA CELLS IN-VITRO, Cancer research, 57(19), 1997, pp. 4309-4315
INDUCTION OF P21(WAF1) EXPRESSION AND GROWTH-INHIBITION BY TRANSFORMING-GROWTH-FACTOR-BETA INVOLVE THE TUMOR-SUPPRESSOR GENE DPC4 IN HUMAN PANCREATIC ADENOCARCINOMA CELLS
Authors: GRAU AM ZHANG L WANG WX RUAN SB EVANS DB ABBRUZZESE JL ZHANG W CHIAO PJ
Citation: Am. Grau et al., INDUCTION OF P21(WAF1) EXPRESSION AND GROWTH-INHIBITION BY TRANSFORMING-GROWTH-FACTOR-BETA INVOLVE THE TUMOR-SUPPRESSOR GENE DPC4 IN HUMAN PANCREATIC ADENOCARCINOMA CELLS, Cancer research, 57(18), 1997, pp. 3929-3934
ARE TIME OR INTENSITY FACTORS IMPORTANT TO THE DEFINITION OF METASTASES OF UNKNOWN ORIGIN
Authors: ABBRUZZESE JL ABBRUZZESE MC LENZI R RABER MN HESS KR
Citation: Jl. Abbruzzese et al., ARE TIME OR INTENSITY FACTORS IMPORTANT TO THE DEFINITION OF METASTASES OF UNKNOWN ORIGIN, Journal of the National Cancer Institute, 88(7), 1996, pp. 462-463
PHASE-I CLINICAL AND PLASMA AND CELLULAR PHARMACOLOGICAL STUDY OF TOPOTECAN WITHOUT AND WITH GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: ABBRUZZESE JL MADDEN T SUGARMAN SM ELLIS AL LOUGHLIN S HESS KR NEWMAN RA ZWELLING LA RABER MN
Citation: Jl. Abbruzzese et al., PHASE-I CLINICAL AND PLASMA AND CELLULAR PHARMACOLOGICAL STUDY OF TOPOTECAN WITHOUT AND WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, Clinical cancer research, 2(9), 1996, pp. 1489-1497
BCL-2 AND P53 EXPRESSION IN RESECTABLE PANCREATIC ADENOCARCINOMAS - ASSOCIATION WITH CLINICAL OUTCOME
Authors: SINICROPE FA EVANS DB LEACH SD CLEARY KR FENOGLIO CJ LEE JJ ABBRUZZESE JL
Citation: Fa. Sinicrope et al., BCL-2 AND P53 EXPRESSION IN RESECTABLE PANCREATIC ADENOCARCINOMAS - ASSOCIATION WITH CLINICAL OUTCOME, Clinical cancer research, 2(12), 1996, pp. 2015-2022
MOLECULAR DIAGNOSIS OF EXOCRINE PANCREATIC-CANCER USING A PERCUTANEOUS TECHNIQUE
Authors: EVANS DB FRAZIER ML CHARNSANGAVEJ C KATZ RL LARRY L ABBRUZZESE JL
Citation: Db. Evans et al., MOLECULAR DIAGNOSIS OF EXOCRINE PANCREATIC-CANCER USING A PERCUTANEOUS TECHNIQUE, Annals of surgical oncology, 3(3), 1996, pp. 241-246
ADENOCARCINOMA OF THE PANCREAS - RECENT CONTROVERSIES, CURRENT MANAGEMENT, AND FUTURE THERAPIES
Authors: EVANS DB STALEY CA LEE JE PISTERS PWT ABBRUZZESE JL
Citation: Db. Evans et al., ADENOCARCINOMA OF THE PANCREAS - RECENT CONTROVERSIES, CURRENT MANAGEMENT, AND FUTURE THERAPIES, GI cancer, 1(3), 1996, pp. 149-161
THE NEED FOR STANDARDIZED PATHOLOGICAL STAGING OF PANCREATICODUODENECTOMY SPECIMENS
Authors: STALEY CA CLEARY KR ABBRUZZESE JL LEE JE AMES FC FENOGLIO CJ EVANS DB
Citation: Ca. Staley et al., THE NEED FOR STANDARDIZED PATHOLOGICAL STAGING OF PANCREATICODUODENECTOMY SPECIMENS, Pancreas, 12(4), 1996, pp. 373-380
Risultati: 1-25 | 26-50 | 51-57